RHBB Psychology Neuropsychology PLLC
RHBB Psychology Neuropsychology PLLC is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Single Arm, Open Label Multicentre Extension Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients with Multiple Sclerosis Previously Enrolled in A F. Hoffmann-La Roche Sponsored Ocrelizumab Phase IIIb/IV Clinical Trial
Sponsor F. Hoffmann-La Roche AG
- Start (EU)
- Latest update
- Estimated end
Operational learnings available5 trial-level findings · Read insights
- Seventy-five CASTING participants discontinued because of country-specific early trial closure.
- The Timed 25-Foot Walk Test and Timed Nine-Hole Peg Test were not applicable to participants rolling over from CASTING.
- Eligibility criteria were updated in August 2020 and March 2021.
- The ocrelizumab infusion duration was reduced from 3.5 hours to 2.0 hours in August 2020.
- The safety follow-up was changed to 48 weeks after the last infusion, and additional follow-up until B-cell repletion was removed in March 2021.
These findings describe the trial, not the service provider’s performance or responsibility.
An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients with Progressive Multiple Sclerosis
Sponsor F. Hoffmann-La Roche AG
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for RHBB Psychology Neuropsychology PLLC?
The 2026-10-09 snapshot links RHBB Psychology Neuropsychology PLLC to 2 distinct CTIS trials. Recorded services include Central Reader BICAMS, central reader for BICAMS. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for RHBB Psychology Neuropsychology PLLC?
The most frequently recorded therapeutic areas are Neurology, Immunology. Recorded phases include Phase 3, Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to RHBB Psychology Neuropsychology PLLC conducted?
The linked trials record locations in 16 countries, including Denmark, France, Italy, Netherlands, Poland. These are trial locations, not confirmed office locations or countries where RHBB Psychology Neuropsychology PLLC delivered services.
What can this page tell me about RHBB Psychology Neuropsychology PLLC's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under RHBB Psychology Neuropsychology PLLC. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- RHBB Psychology Neuropsychology PLLC